Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 460

1.

Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H.

Eur J Radiol. 2010 Jul;75(1):e126-32. doi: 10.1016/j.ejrad.2009.09.013. Epub 2009 Sep 30.

PMID:
19796900
2.

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.

J Magn Reson Imaging. 2008 Nov;28(5):1157-65. doi: 10.1002/jmri.21570.

PMID:
18972357
3.

Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.

Imamura T, Isomoto I, Sueyoshi E, Yano H, Uga T, Abe K, Hayashi T, Honda S, Yamaguchi T, Uetani M.

Magn Reson Med Sci. 2010;9(4):217-25.

4.

Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.

Lo GG, Ai V, Chan JK, Li KW, Cheung PS, Wong TT, Ma M, Lee R, Chien D.

J Comput Assist Tomogr. 2009 Jan-Feb;33(1):63-9. doi: 10.1097/RCT.0b013e318165dc6b.

PMID:
19188787
5.

Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.

J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.

PMID:
20657216
6.

Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.

Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD.

AJR Am J Roentgenol. 2009 Dec;193(6):1716-22. doi: 10.2214/AJR.08.2139.

PMID:
19933670
7.

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.

Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.

Acta Radiol. 2008 Dec;49(10):1207-13. doi: 10.1080/02841850802508959.

PMID:
19031184
8.

Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.

Choi N, Han BK, Choe YH, Kim HS.

J Comput Assist Tomogr. 2005 Nov-Dec;29(6):834-41.

PMID:
16272861
10.

1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?

Tozaki M, Fukuma E.

AJR Am J Roentgenol. 2009 Sep;193(3):840-9. doi: 10.2214/AJR.08.2128.

PMID:
19696300
11.

Diagnostic value of MR elastography in addition to contrast-enhanced MR imaging of the breast-initial clinical results.

Siegmann KC, Xydeas T, Sinkus R, Kraemer B, Vogel U, Claussen CD.

Eur Radiol. 2010 Feb;20(2):318-25. doi: 10.1007/s00330-009-1566-4. Epub 2009 Sep 1.

PMID:
19727753
12.

Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.

Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.

J Vasc Interv Radiol. 2007 Aug;18(8):957-63.

PMID:
17675611
13.

ADC mapping of benign and malignant breast tumors.

Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M, Hayakawa K.

Magn Reson Med Sci. 2005;4(1):35-42.

14.

Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.

Yoo H, Shin HJ, Baek S, Cha JH, Kim H, Chae EY, Kim HH.

Magn Reson Imaging. 2014 Sep;32(7):867-74. doi: 10.1016/j.mri.2014.04.012. Epub 2014 Apr 24.

PMID:
24907855
15.

Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.

Tan SL, Rahmat K, Rozalli FI, Mohd-Shah MN, Aziz YF, Yip CH, Vijayananthan A, Ng KH.

Clin Radiol. 2014 Jan;69(1):63-71. doi: 10.1016/j.crad.2013.08.007. Epub 2013 Oct 22.

PMID:
24156797
16.

Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.

Goto M, Ito H, Akazawa K, Kubota T, Kizu O, Yamada K, Nishimura T.

J Magn Reson Imaging. 2007 Jan;25(1):104-12.

PMID:
17152054
17.

Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.

Gokalp G, Topal U, Yildirim N, Tolunay S.

Eur J Radiol. 2012 Feb;81(2):203-8. doi: 10.1016/j.ejrad.2010.12.022. Epub 2011 Jan 13.

PMID:
21236612
18.

Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.

Ei Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ, Bluemke DA.

Radiology. 2010 Jul;256(1):64-73. doi: 10.1148/radiol.10091367.

19.

Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.

Jang KM, Kim SH, Hwang J, Lee SJ, Kang TW, Lee MW, Choi D.

AJR Am J Roentgenol. 2014 Oct;203(4):803-12. doi: 10.2214/AJR.13.11914.

PMID:
25247945
20.

Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.

Cheung HS, Tse GM, Lai SY, Yeung DK.

Magn Reson Imaging. 2004 Nov;22(9):1259-64.

PMID:
15607097
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk